XML 47 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes
6 Months Ended
Jun. 30, 2020
Income Tax Disclosure [Abstract]  
Income Taxes INCOME TAXES
The Company recognized income tax expense of $6.1 million and $11.6 million for the three months ended June 30, 2020 and 2019, respectively. The decrease in tax expense in the current-year quarter was largely due to lower pre-tax income levels, and the recognition of a $1.1 million excess tax benefit from stock compensation activity. The Company’s effective tax rate for the three months ended June 30, 2020 was 22.2%, compared to 26.1% in the prior-year quarter.
For the six months ended June 30, 2020 and 2019, the Company recognized income tax expense of $13.3 million and $17.5 million, respectively. The decrease in tax expense in the current year was largely due to lower pre-tax income levels, and the recognition of excess tax benefits from stock compensation activity of $1.8 million. The Company’s effective tax rate for the six months ended June 30, 2020 was 22.9%, compared to 25.8% in the prior-year period.
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted. The income tax provisions of the CARES Act had limited applicability to the Company and, therefore, did not have a material impact on the Company’s income tax expense for the three and six months ended June 30, 2020. However, as permitted under the CARES Act, the Company elected to defer approximately $3.3 million of federal income tax payments, that would have otherwise been paid during the second quarter of 2020, to the third quarter of 2020.